the main goal of founding the company was to ensure pharmaceutical substances and intermediates to several finished drug form manufacturing plants in the soviet union as a result of privatization in 1997 the company was reorganized into a joint stock company and its shares were listed on stock exchange olainfarm produces over 60 final dosage forms 25 active pharmaceutical ingredients and 20 intermediates the product portfolio is well diversified with the main emphasis on branded products historically unique to olainfarm the key areas of specialization in final dosage forms include neurology cholinesterase inhibitors anxiolytics psychostimulants nootropics cardiology antiarrhythmics energy metabolism enhancers infectology original nitrofurantoine derivatives and antivirals and allergology fast acting antihistamines olainfarm is certified in accordance with the requirements of the eu gmp for apis and fdfs the u s cgmp for certain apis fda tga for fdfs australia cep for certain apis iso 14001 environmental management system and iso 17025 laboratory management system proof of the high quality of the olainfarm products is cooperation with such global and regionally acknowledged companies as novartis dr reddy s glenmark generics sigma au almirall ranke uquifa miat actavis teva egis phf and many others since 2011 olainfarm supplies anti tuberculosis medication